List of Studies ( Metabolite:Vigabatrin)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004200 | AN006985 | untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS | Blood | Mouse | Environmental exposure | University of Washington | LC-MS |
| ST004200 | AN006986 | untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS | Blood | Mouse | Environmental exposure | University of Washington | LC-MS |
| ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | LC-MS | |
| ST002761 | AN004489 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | LC-MS | |
| ST002698 | AN004372 | Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites | Infected Red Blood Cells | Plasmodium berghei | Malaria | Peter Doherty Institute for Infection and Immunity | LC-MS |
| ST001784 | AN002895 | Validation of the classifying model by OLA and CLO therapy cases | Blood | Mouse | Hebei medical university | LC-MS | |
| ST001783 | AN002894 | Performance of Three Differential Metabolites at Different TSS within 20 days | Blood | Mouse | Hebei medical university | LC-MS | |
| ST001782 | AN002893 | Examining the Identified Differential Metabolites in Other Antipsychotics with a High Fatality Frequency (part IV) | Blood | Mouse | Hebei medical university | LC-MS | |
| ST001781 | AN002892 | Identifying Candidate Differential Metabolites in lethal chlorpromazine poisoning Relative to non-drug related deaths (part III) | Blood | Mouse | Hebei medical university | LC-MS | |
| ST001746 | AN002842 | Examining the Identified Differential Metabolites in Other Antipsychotics with a High Fatality Frequency | Blood | Mouse | Hebei medical university | LC-MS | |
| ST001739 | AN002832 | Differential Metabolites and Disturbed Metabolic Pathways Associated with chlorpromazine Poisoning | Blood | Mouse | Hebei medical university | LC-MS | |
| ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000665 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
